Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24588

Xla Wt + six1-400, Mehdizadeh T et al. (2021)

Experiment + Assay: Xla Wt + six1-400 + NF26-32 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
mRNA injection six1 (Xla) six1 (Xla)
 NF stage 4 (8-cell) animal blastomere
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 26 to NF stage 32  
Expression Phenotypes (1):
decreased amount spry1.L expression in otic vesicle
Human Disease Associations: branchiootorenal syndrome
Source: Fig. 2HJ
Article: XB-ART-58245, PubMed